← Back to Clinical Trials
Recruiting NCT05281055

NCT05281055 Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05281055
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Stroke, Ischemic
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2019-01-01
Primary Completion 2030-12-31

Trial Parameters

Condition Stroke, Ischemic
Sponsor National Taiwan University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,000
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2019-01-01
Completion 2030-12-31
Interventions
Endovascular thrombectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke is a multi-centers registration. It starts in Jan 2019. The key items in the registration form include basic demographic profiles, past medical history, time of stroke onset, stroke severity (NIH stroke scale), whether to have rt-PA treatment, pre-EVT imaging, type of devices, status of recanalization, complication and other associated parameters for EVT, and 3 months post stroke outcome. The study also includes a standardized imaging analysis for the quantification of the de-identified imaging data from participates. In summary, the registry will provide the valuable information for AIS patients receiving EVT in Twain.

Eligibility Criteria

Inclusion Criteria: * Acute ischemic stroke caused by intracranial large vessel occlusion * Can be treated within 24 hours of stroke onset. * Large vessel occlusion demonstrated by magnetic resonance imaging angiography (MRA), computed tomography angiography (CTA) or digital substraction angiography (DSA). * Pre-stroke independence (modified Rankin Scale 0-2). Exclusion Criteria: * Other cause of stroke, such as intracranial hemorrhage. * Not underwent endovascular thrombectomy

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology